Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00939523
Title Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.